Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tivozanib (Standard)

Tivozanib (Standard) is the analytical standard of Tivozanib. This product is intended for research and analytical applications. Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR) -1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor efficacy[1].

Product Specifications

CAS Number

475108-18-0

UNSPSC

12352100

Target

Reference Standards; VEGFR

Related Pathways

Others; Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Smiles

O=C(NC1=CC=C(C=C1Cl)OC2=CC=NC3=CC(OC)=C(C=C23)OC)NC4=NOC(C)=C4

Molecular Formula

C22H19ClN4O5

Molecular Weight

454.86

References & Citations

[1]Nakamura K, et al., KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res. 2006 Sep 15;66 (18) :9134-42.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Thromboxane A2 receptor Antibody
RC-16539-01 50 μL

Recombinant Thromboxane A2 receptor Antibody

Sign In for Pricing
View Details
Recombinant Thromboxane A2 receptor Antibody
RC-16539-02 100 µL

Recombinant Thromboxane A2 receptor Antibody

Sign In for Pricing
View Details
Recombinant Thromboxane A2 receptor Antibody
RC-16539-03 1 mL

Recombinant Thromboxane A2 receptor Antibody

Sign In for Pricing
View Details
Frozen Tissue Blocks, Kidney
CB517099 1 Block

Frozen Tissue Blocks, Kidney

Sign In for Pricing
View Details
Frozen Tissue Sections, Breast
CS624415 5x 5 µm

Frozen Tissue Sections, Breast

Sign In for Pricing
View Details
ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), CF640R conjugate, 0.1mg/mL
BNC403260-500 1x 500 µL

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details